In a new cross-sectional and longitudinal study, researchers from the University of Turku and Turku University Hospital investigated the effects of dietary caffeine intake on dopamine function and clinical symptoms in Parkinson’s disease. Chronic caffeine intake prompts compensatory and cumulative dopamine transporter downregulation, consistent with caffeine’s reported risk reduction in Parkinson’s disease. Image credit: Clinical Neurosciences,...